D.E. Clark

1.3k total citations
16 papers, 1.0k citations indexed

About

D.E. Clark is a scholar working on Obstetrics and Gynecology, Molecular Biology and Immunology. According to data from OpenAlex, D.E. Clark has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in D.E. Clark's work include Pregnancy and preeclampsia studies (9 papers), Reproductive System and Pregnancy (7 papers) and Angiogenesis and VEGF in Cancer (5 papers). D.E. Clark is often cited by papers focused on Pregnancy and preeclampsia studies (9 papers), Reproductive System and Pregnancy (7 papers) and Angiogenesis and VEGF in Cancer (5 papers). D.E. Clark collaborates with scholars based in United Kingdom, New Zealand and Denmark. D.E. Clark's co-authors include D. Stephen Charnock‐Jones, S. K. Smith, Andrew Sharkey, D Licence, Jason Cooper, J. McLaren, N. H. MORRIS, Tanya D. Burrows, Ashley King and Y.W. Loke and has published in prestigious journals such as British Journal of Pharmacology, Human Reproduction and Biology of Reproduction.

In The Last Decade

D.E. Clark

16 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.E. Clark United Kingdom	14	588	434	406	242	179	16	1.0k
D Licence United Kingdom	7	393 0.7×	406 0.9×	291 0.7×	86 0.4×	316 1.8×	7	816
Friederike Herr Germany	9	524 0.9×	400 0.9×	243 0.6×	292 1.2×	207 1.2×	14	963
Diana R. Licence United Kingdom	10	467 0.8×	312 0.7×	422 1.0×	246 1.0×	108 0.6×	10	950
Katsuji Kokawa Japan	16	390 0.7×	426 1.0×	227 0.6×	72 0.3×	287 1.6×	27	920
Damyanti Bhardwaj Canada	7	376 0.6×	261 0.6×	240 0.6×	201 0.8×	45 0.3×	8	672
Hua Zhu Canada	18	359 0.6×	293 0.7×	300 0.7×	138 0.6×	134 0.7×	30	755
Hirokazu Usui Japan	15	248 0.4×	114 0.3×	345 0.8×	175 0.7×	208 1.2×	71	932
Tomoko Saito‐Fujita Japan	12	433 0.7×	408 0.9×	142 0.3×	273 1.1×	162 0.9×	15	812
B A Dsupin United States	12	492 0.8×	412 0.9×	194 0.5×	294 1.2×	535 3.0×	14	1.4k
Jun Lin China	23	693 1.2×	474 1.1×	236 0.6×	87 0.4×	777 4.3×	68	1.3k

Countries citing papers authored by D.E. Clark

Since Specialization

Citations

This map shows the geographic impact of D.E. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.E. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.E. Clark more than expected).

Fields of papers citing papers by D.E. Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.E. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.E. Clark. The network helps show where D.E. Clark may publish in the future.

Co-authorship network of co-authors of D.E. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of D.E. Clark. A scholar is included among the top collaborators of D.E. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.E. Clark. D.E. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Clark, D.E., et al.. (2009). BGC20‐1531, a novel, potent and selective prostanoid EP₄receptor antagonist: a putative new treatment for migraine headache. British Journal of Pharmacology. 156(2). 316–327. 47 indexed citations

Charnock‐Jones, D. Stephen, et al.. (2001). Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs. Reproduction. 122(5). 753–760. 40 indexed citations

Smith, S. K., Yulong He, D.E. Clark, & D. Stephen Charnock‐Jones. (2000). Angiogenic growth factor expression in placenta. Seminars in Perinatology. 24(1). 82–86. 18 indexed citations

Sharkey, Andrew, Ashley King, D.E. Clark, et al.. (1999). Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy1. Biology of Reproduction. 60(2). 355–364. 106 indexed citations

Clark, D.E., Jannie Dalby Salvig, S. K. Smith, & D. Stephen Charnock‐Jones. (1998). Hepatocyte growth factor levels during normal and intra-uterine growth-restricted pregnancies. Placenta. 19(8). 671–673. 20 indexed citations

Clark, D.E., et al.. (1998). Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. Journal of Endocrinology. 159(3). 459–467. 163 indexed citations

Wetzka, B., D.E. Clark, D. Stephen Charnock‐Jones, H. P. Zahradnik, & S. K. Smith. (1997). Isolation of macrophages (Hofbauer cells) from human term placenta and their prostaglandin E2 and thromboxane production. Human Reproduction. 12(4). 847–852. 44 indexed citations

Clark, D.E., et al.. (1997). Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.. PubMed. 77(6). 607–14. 94 indexed citations

Clark, D.E., S. K. Smith, Andrew Sharkey, Heidi Sowter, & D. Stephen Charnock‐Jones. (1996). Hepatocyte growth factor/scatter factor and its receptor c-met: localisation and expression in the human placenta throughout pregnancy. Journal of Endocrinology. 151(3). 459–467. 45 indexed citations

10.

Sharkey, Andrew, Jason Cooper, J. McLaren, et al.. (1996). Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre‐eclampsia. European Journal of Clinical Investigation. 26(12). 1182–1185. 118 indexed citations

11.

Clark, D.E., S. K. Smith, Andrew Sharkey, & D. Stephen Charnock‐Jones. (1996). Localization of VEGF and expression of its receptors flit and KDR in human placenta throughout pregnancy. Human Reproduction. 11(5). 1090–1098. 232 indexed citations

12.

Clark, D.E., D. J. Tisdall, Andrew E. Fidler, & K. P. McNatty. (1996). Localization of mRNA encoding c-kit during the initiation of folliculogenesis in ovine fetal ovaries. Reproduction. 106(2). 329–335. 41 indexed citations

13.

Sharkey, Andrew, Sanjay Verma, Lindsey R. Hayes, et al.. (1996). Expression and localisation of the receptor for leukemia inhibitory factor in human trophoblast and decidua. Placenta. 17(5-6). A36–A36. 1 indexed citations

14.

Clark, D.E., et al.. (1994). Temporal changes to uterine collagen types I, III and V in relation to early pregnancy in the rat. Reproduction Fertility and Development. 6(6). 669–677. 18 indexed citations

15.

Clark, D.E., et al.. (1992). Collagen concentrations in dissected tissue compartments of rat uterus on Days 6, 7 and 8 of pregnancy. Reproduction. 94(1). 169–175. 15 indexed citations

16.

Clark, D.E., et al.. (1990). Decreased collagen concentration in rat uterine implantation sites compared with non-implantation tissue at days 6-11 of pregnancy. Reproduction Fertility and Development. 2(6). 607–612. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact